Journey Medical Corporation
DERM
$7.48
$0.030.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 12.05% | -0.90% | |||
| Total Other Revenue | 1,577.50% | 207.69% | |||
| Total Revenue | 15.97% | -0.73% | |||
| Cost of Revenue | -1.21% | 14.30% | |||
| Gross Profit | 26.93% | -8.42% | |||
| SG&A Expenses | 7.71% | 2.49% | |||
| Depreciation & Amortization | -13.94% | 5.73% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.44% | 5.63% | |||
| Operating Income | 130.56% | -236.79% | |||
| Income Before Tax | 86.68% | -78.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 86.01% | -78.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 86.01% | -78.83% | |||
| EBIT | 130.56% | -236.79% | |||
| EBITDA | 489.34% | -158.84% | |||
| EPS Basic | 86.17% | -77.61% | |||
| Normalized Basic EPS | 86.67% | -77.08% | |||
| EPS Diluted | 86.17% | -77.61% | |||
| Normalized Diluted EPS | 86.67% | -77.08% | |||
| Average Basic Shares Outstanding | 0.69% | 0.74% | |||
| Average Diluted Shares Outstanding | 0.69% | 0.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||